首页> 外国专利> FIBROCYTE GROWTH FACTOR SUSTAINED-RELEASE BIOMATERIAL

FIBROCYTE GROWTH FACTOR SUSTAINED-RELEASE BIOMATERIAL

机译:持续增长的生物纤维化因子

摘要

PROBLEM TO BE SOLVED: To solve a problem that when implanting a biomaterial in a living body, fibrocyte growth factor (FGF-2) is effective for promoting its fixing and bonding with peripheral tissues such as a bone and a skin, however, materials sustainably releasing an appropriate amount of FGF-2 for tissue regeneration having activity, to an implanted site of the biomaterial for a long time are limited to organic materials with biodegradability so far, even if covering the biomaterial, the FGF-2 may be peeled off in the implantation due to the difference in the mechanical strength and prevents the direct contact between the biomaterial and the peripheral tissue and it is not always optimal for the promotion of the fixing and bonding.;SOLUTION: Immersion liquid is prepared by dissolving FGF-2 in calcium phosphate supersaturated solution prepared by mixing three types of more medical infusions, and a composite layer of FGF-2 and low-crystalline apatite is deposited on a biomaterial surface formed of anodized titanium or hydroxyapatite. The thickness of the layer and FGF-2 content can be controlled by changing the solution composition and the possibility of peeling when implanted is low due to direct formation thereof on the biomaterial surface.;COPYRIGHT: (C)2009,JPO&INPIT
机译:要解决的问题:为了解决在生物体内植入生物材料时,纤维细胞生长因子(FGF-2)能有效促进其与骨骼和皮肤等周围组织的固定和结合的问题,但是这种材料可以持久迄今为止,向生物材料的植入部位长时间释放适量的FGF-2以用于具有活性的组织再生的方法仅限于具有生物可降解性的有机材料,即使覆盖生物材料,FGF-2也可能被剥离。由于机械强度的差异而导致植入,并且阻止了生物材料与周围组织之间的直接接触,并且对于促进固定和键合并非总是最佳方法。解决方案:将FGF-2溶解在通过混合三种类型的更多医用输液制备的磷酸钙超饱和溶液,并将FGF-2和低结晶磷灰石的复合层沉积在生物材料表面表面由阳极氧化钛或羟基磷灰石形成。层的厚度和FGF-2的含量可以通过改变溶液的组成来控制,并且由于在生物材料表面直接形成而导致植入时剥离的可能性低。;版权所有:(C)2009,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号